Ennovation Ventures
VC Fund
Shanghai, China
Ennovation Ventures is a venture capital firm that focuses on biomedical and medical health.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 36%
Last updated:
For AI agents: llms.txt
Industries Ennovation Ventures invests in
Stages Ennovation Ventures invests in
Countries Ennovation Ventures invests in
Investment Focus
Industry
- Medical 4 (36%)
- Health Care 3 (27%)
- Biotechnology 3 (27%)
- Pharmaceutical 2 (18%)
- Database 1 (9%)
Stage
- Seed 4 (36%)
- Series A 4 (36%)
- Series B 3 (27%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Sinzen Medtech
|
Sinzen Medtech is a medical technology company that specializes in minimally invasive surgical and tumor treatments. | Series A / May 19, 2026 | |
|
Proviva Therapeutics, Inc
|
Prodrug design platform for cytokines and other fusion proteins | $18M / Series A / Mar 05, 2024 | |
Hope Medicine
|
Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases. | $28.1M / Series B / Feb 07, 2024 | |
Zenshine Pharma
|
Zenshine Pharma is a clinical-stage biopharmaceutical company with a focus on the development of small molecule drugs for cancer, viral infections, and autoimmune diseases. | Series B / Mar 11, 2023 | |
Nanjing Orui Pharmaceutical
|
Nanjing Orui Pharmaceutical focuses on research and development of antiviral drugs with unique ideas. | $15.7M / Seed / Mar 27, 2022 | |
Human Zhizao
|
Human Intelligent Manufacturing is a fully automatic multiple flow fluorescence platform. | Seed / Mar 21, 2022 | |
InxMed
|
InxMed is a clinical-stage biotech company focusing on developing "Best-in-Disease Combination" medicines to bring novel treatment options for patients. Our innovations are inspired by patients and driven by an in-depth understanding of disease biology and pharmacology. InxMed is committed to building a translational platform equippedwith global-level top-notch know-how and efficient execution capabilities. | $50M / Series B / Mar 03, 2022 | |
Purui
|
Purui is a life big data service provider. | $14.2M / Seed / Feb 10, 2022 | |
Prime Lifescience
|
Prime Lifescience is a developer of a big data platform that focuses on life sciences. The company is dedicated to establishing a health lifecycle big data collaboration network through digital technology innovation and extensive use of artificial intelligence. They offer a digital smart health community, a digital intelligent clinical researchaccelerator, and a live big data platform as part of their offering. | $15.7M / Seed / Jan 28, 2022 | |
|
Zenshine Pharma
|
Zenshine Pharma is a clinical-stage biopharmaceutical company with a focus on the development of small molecule drugs for cancer, viral infections, and autoimmune diseases. | $15M / Series A / Dec 01, 2020 | |
| See all 11 investments → | |||
Co-Investors
Qiming Venture Partners
4 deals together
China Growth Capital
1 deal together
CMG-SDIC Capital Management
1 deal together
CS Capital
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Ennovation Ventures invest in?
Ennovation Ventures invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 11 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Ennovation Ventures last invest?
The most recent investment recorded for Ennovation Ventures closed in May 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
